Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
237.00    0.00 (0.00%)
Bid:
230.00
Ask:
244.00
Spread: 14.00 (6.087%)
Market Cap: £26.39m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

Holding(s) in Company

2 Jul 2009 14:11

RNS Number : 0281V
Alkane Energy PLC
02 July 2009
Β 

ο»Ώ

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerΒ of existing shares to which voting rights areΒ attached:

Β Alkane Energy plc

2 Reason for the notificationΒ (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YESΒ 

An acquisition or disposal ofΒ qualifyingΒ financial instruments which may result in theΒ acquisition of shares already issuedΒ to which voting rights are attached

NOΒ 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

Β NO

An event changing the breakdown of voting rights

Β NO

Other (please specify):

Β NO

3. Full name of person(s) subject to theΒ notification obligation:

Β Gartmore Investment Limited

4. Full name of shareholder(s)Β (if differentΒ from 3.):

See section 9

5. Date of the transaction and date onΒ which the threshold is crossed orΒ reached:

Β 30thΒ June 2009

6.Β Date on which issuer notified:

1stΒ July 2009

7. Threshold(s) that is/are crossed orΒ reached:

Β 27%

Β Β 

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to theΒ triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Β GB003286613

24,349,997Β 

24,349,997Β 

25,274,997Β 

Β 

25,274,997Β 

Β 

27.211%Β 

Β 

B:Β QualifyingΒ Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/Β ConversionΒ Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

Β 

Β 

Β 

Β 

Β 

C:Β FinancialΒ Instruments with similar economic effect to QualifyingΒ FinancialΒ Instruments

Resulting situation after the triggering transaction

Type of financial instrument

ExerciseΒ price

ExpirationΒ date

Exercise/ ConversionΒ period

Number of votingΒ rights instrumentΒ refers to

% of voting rights

Β 

Β 

Β 

Β 

Β 

Nominal

Delta

Β 

Β 

Total (A+B+C)

Number of voting rights

PercentageΒ of voting rights

Β 25,274,997

27.211%Β 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Funding Managing Company

Shares Held

% of Issued Share Capital

UKΒ Registered Owner

UKΒ Registered Owner

Gartmore Investment Limited

24,209,997

1,065,000

26.065%

1.147%

Tartan Investment Partners

Tartan Investment Partners

25,274,997

27.211%

Vidacos Nominees Ltd A/C 2303

The Alphagen Volantis Fund Limited

25,274,997

27.211%

Proxy Voting:

10. Name of the proxy holder:

Β 

11. Number of voting rights proxy holder will ceaseΒ to hold:

Β 

12. Date on which proxy holder will cease to holdΒ voting rights:

Β 

13. Additional information:

All figures are based on the Company's issued share capital of 92,883,878 as provided by Exshare

Email contact RDU@Gartmore.com

14. Contact name:

Β RDU

15. Contact telephone number:

Β 0207 782 2324

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLUUUUGMUPBGWP
Date   Source Headline
15th Jun 20267:01 amRNSTees Valley Lithium: Publication of Impact Report
15th Jun 20267:00 amRNSIssue of Shares
10th Jun 20267:00 amRNSNotice of AGM
28th May 20267:00 amRNSAnnual Report & Financial Statements
24th Apr 20267:00 amRNSTVL Project Development Update
19th Mar 20267:00 amRNSTVL Industry Engagement Update
27th Feb 20263:00 pmRNSLoan Conversion
24th Feb 20267:00 amRNSTVL Appoints Wates group
12th Feb 20267:00 amRNSTVL Advances On-Site Lithium Recovery
5th Feb 20263:26 pmRNSGrant of Share Awards
3rd Feb 20267:00 amRNSTVL FEED Study
29th Jan 20264:07 pmRNSLoan Conversion
28th Jan 20269:35 amRNSTVL and Glencore Sign Binding Offtake Agreement
14th Jan 20267:00 amRNSTVL FEED Study Update
9th Dec 202511:40 amRNSLoan Conversion
27th Nov 20253:00 pmRNSExercise of Warrants and Loan Conversion
10th Nov 20257:00 amRNSTees Valley Lithium Financing and Project Delivery
5th Nov 20257:00 amRNSAppointment of ABG Sundal Collier ASA
3rd Nov 20251:28 pmRNSExercise of Warrants
29th Oct 20254:23 pmRNSExercise of Warrants
15th Oct 20257:00 amRNSInterim Results
9th Oct 20257:00 amRNSTVL: Appointment of COO & Launch of OEP
6th Oct 20257:00 amRNSTVL: Lower CAPEX, Higher Uptime, Stronger Outlook
29th Aug 20257:00 amRNSTVL Project and Leadership Update
31st Jul 20253:00 pmRNSExercise of Warrants
31st Jul 20257:00 amRNSFEED Funding and Equity Funding Proposal
17th Jul 20257:00 amRNSTVL Secures Binding Feedstock Agreement
25th Jun 20257:00 amRNSOversubscribed Subscription to raise £500,000
18th Jun 20251:00 pmRNSResult of AGM
2nd Jun 20257:05 amRNSAlkemy Shareholder Call
2nd Jun 20257:00 amRNSTVL Update: Process Validated, CAPEX Confirmed
23rd May 20253:00 pmRNSNotice of AGM
21st May 20254:30 pmRNSFinal Results
12th May 20257:05 amRNS-RAlkemy Shareholder Call
12th May 20257:00 amRNSExclusivity Agreement Signed with Ara Partners
18th Mar 20257:00 amRNSTVL - Exclusive Negotiation for Lithium Supply
18th Feb 20257:00 amRNSTVL Appoints New CEO and Commences FEED Study
17th Feb 20258:27 amRNSReplacement: Subscription to raise £0.75 million
17th Feb 20257:00 amRNSPlacing to raise £1.035 million
31st Jan 20257:00 amRNSTVL Collaborates with Veolia
6th Nov 20247:00 amRNSChairman Share Purchases
24th Oct 20248:00 amRNSABG Sundal Collier to lead US$25m Convertible Bond
2nd Oct 20247:00 amRNSInterim Results
5th Aug 20247:00 amRNSCorporate Update
2nd Jul 20242:00 pmRNSResult of AGM
5th Jun 20244:30 pmRNSNotice of AGM
30th May 20244:30 pmRNSAnnual Report & Financial Statements
26th Feb 20247:00 amRNSChange of Adviser
30th Jan 20247:00 amRNSMOU with Syrah for UK’s first Graphite refinery
18th Jan 20247:00 amRNSCorporate Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.